CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer
Su-Jung Kim, Soyeon Kim, Dong-Wan Kim, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yusoo Lee, Jaemoon Koh, Yoon Kyung Jeon, Dae Seog Heo
Cancer Research and Treatment. 2019;51(3):1231-1240.   Published online 2018 December 31    DOI: https://doi.org/10.4143/crt.2018.486

Excel Download

Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer
Cancer Research and Treatment. 2019;51(3):1231-1240   Crossref logo
Link1 Link2 Link3

Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors
Lung Cancer. 2016;102:38-41   Crossref logo
Link1 Link2

A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case report
OncoTargets and Therapy. 2016;Volume 9:6059-6063   Crossref logo
Link1 Link2

Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor
Lung Cancer. 2019;127:66-68   Crossref logo
Link1 Link2

Response to pemetrexed rechallenge after acquired resistance of ALK inhibitors
Lung Cancer. 2016;102:135   Crossref logo
Link1 Link2

Overcoming crizotinib resistance in ALK-rearranged non-small cell lung cancer
Lung Cancer. 2014;85(2):335-336   Crossref logo
Link1 Link2

Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma
Lung Cancer. 2016;92:15-18   Crossref logo
Link1 Link2

ALK-Rearranged Squamous Cell Carcinoma of the Lung Treated with Two Lines of ALK Inhibitors
Journal of Thoracic Oncology. 2017;12(5):e55-e57   Crossref logo
Link1 Link2

Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
Lung Cancer. 2014;83(1):37-43   Crossref logo
Link1 Link2

PD-L1 expression in ROS1 -rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR , ALK , and ROS1
Thoracic Cancer. 2018;10(1):103-110   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.